Temporal patterns of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography sinonasal uptake after treatment of sinonasal malignancy
- 7 July 2016
- journal article
- research article
- Published by Wiley in International Forum of Allergy & Rhinology
- Vol. 6 (12) , 1301-1307
Abstract
Background: Current guidelines have identified 10 to 12 weeks posttreatment as the ideal time‐point for improved diagnostic accuracy of positron emission tomography/computed tomography (PET/CT) for deep tissue sites of the head and neck. After treatment, the sinonasal skull base is predisposed to prolonged inflammation that may render this time‐point inappropriate for initial posttreatment imaging surveillance for sinonasal malignancies. The purpose of this study is to evaluate temporal trends in 18F‐fluorodeoxyglucose (18FDG) sinonasal uptake after treatment for sinonasal malignancies to better elucidate the optimal time‐point for initial PET/CT posttreatment evaluation in this patient population.Methods: A retrospective analysis of all successfully treated and non–locally recurrent sinonasal malignancies over a 15‐year study period (2000 to 2015) was performed at our institution. Posttreatment 18FDG PET/CT standardized uptake value data were collected and compared between various time‐points (2 to 4 months, 5 to 12 months, 5 to 24 months, and 13 to 24 months) using an independent‐samples t test.Results: A statistically significant difference was noted between the posttreatment time windows 2 to 4 and 5 to 12 months (p = 0.048) as well as 2 to 4 and 5 to 24 months (p = 0.02). A trend toward significance was seen when comparing 2 to 4 and 13 to 24 months (p = 0.083).Conclusion: Our analysis of PET/CT in patients previously treated for sinonasal malignancy suggests that the posttreatment sinonasal skull base is characterized by a prolonged period of hypermetabolism that endures beyond the period previously described for deep tissue sites of the head and neck. These findings prompt a reevaluation of the previously described 10‐ to 12‐week cutoff point for initial posttreatment PET/CT for head and neck squamous cell carcinoma as applied to sinonasal malignancies.Keywords
This publication has 18 references indexed in Scilit:
- Temporal patterns of head and neck squamous cell carcinoma recurrence with positron‐emission tomography/computed tomography monitoringThe Laryngoscope, 2012
- Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- PET/CT in the assessment of previously treated skull base malignanciesHead & Neck, 2009
- Does 18F-FDG PET/CT Improve the Detection of Posttreatment Recurrence of Head and Neck Squamous Cell Carcinoma in Patients Negative for Disease on Clinical Follow-up?Journal of Nuclear Medicine, 2008
- A systematic review and meta‐analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapyClinical Otolaryngology, 2008
- F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinomaOral Oncology, 2007
- Integrated PET/CT system for staging and surveillance of skull base tumorsHead & Neck, 2007
- Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic PatientThe Laryngoscope, 2000
- Nasal mucociliary clearance after radiation therapyThe Laryngoscope, 1995
- Mucociliary activity and ultrastructural abnormalities of regenerated sinus mucosa in rabbitsThe Laryngoscope, 1994